4
98
V. E. Oslovsky et al.
7
. Kolyachkina, S.V.; Tararov, V.I.; Alexeev, C.S.; Krivosheev, D.M.; Romanov, G.A.; Stepanova, E.V.;
Solomko, E.S.; Inshakov, A.N.; Mikhailov, S.N. N6-Substituted adenosines. Cytokinin and antitumor
activities. Collection of Czech. Chem. Commun, 2011, 76, 1361–1378.
8
. a)Arita, M.; Wakita, T.; Shimizu, H. Characterization of pharmacologically active compounds that
inhibit poliovirus and enterovirus 71 infectivity. J. Gen. Virol. 2008, 89, 2518–2530. b) Tararov, V.I.;
Tijsma, A.; Kolyachkina, S.V.; Oslovsky, V.E.; Neyts, J.; Drenichev, M.S.; Leyssen, P.; Mikhailov, S.N.
Chemical modification of the plant isoprenoid cytokinin N6-isopentenyladenosine yields a selective
inhibitor of human enterovirus 71 replication. Eur. J. Med. Chem. 2015, 90, 406–413.
9
. Graci, J.D.; Too, K.; Smidansky, E.D.; Edathil, J.P.; Barr, E.W.; Harki, D.A.; Galarraga, J.E.; Bollinger,
J.M.; Peterson, B.R.; Loakes, D.; Brown, D.M.; Cameron1, C.E. Lethal mutagenesis of picornaviruses with
N -modified purine nucleoside analogues. Antimicrob. Agent Chemother. 2008, 52(3), 971–979.
6
1
0. Herforth, C.; Wiesner, J.; Heidler, P.; Sanderbrand, S.; Van Calenbergh, S.; Jomaa, H.; Link, A.
6
Antimalarial activity of N -substituted adenosine derivatives. Part 3. Bioorg. Med. Chem. 2004, 12,
755–762.
1
1. Bressi, J.C.; Verlinde, C.L.M.J.; Aronov, A.M.; Shaw, M.L.; Shin, S.S.; Nguyen, L.N.; Suresh, S.;
Buckner, F.S.; Van Voorhis, W.C.V.; Kuntz, I.D.; Hol, W.G.J.; Gelb, M.H. Adenosine analogues as
selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of trypanosomatidae via structure-
based drug design. J. Med. Chem. 2001, 44, 2080–2093.
1
2. Ah Kim, Y.; Sharon, A.; Chu, C.K.; Rais, R.H.; Al Safarjalani, O.N.; Naguib, F.N.M.; El Kouni, M.H.
Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues
as potential anti-toxoplasma agents. Biochem. Pharmacol. 2007, 73(10), 1558–1572.
6
1
1
1
1
1
1
1
2
3. Shimazaki, N.; Shima, I.; Hemmi, K.; Hashimoto, M. N -(2,2-Diphenylethyl)adenosine, a novel
adenosine receptor agonist with antipsychotic-like activity. J. Med. Chem. 1987, 30, 1709–1711.
4. Kuhn, R.; Jahn, W.; Dietmann, H.; Dietmann, K. N(6) Alkenyl 5-substituted adenosine. US Patent
Office. 1969, 3.475.408.
6
5. Ottria, R.; Casati, S.; Baldoli, E.; Maier, J.A.M.; Ciuffreda P. N -Alkyladenosines: Synthesis and eval-
uation of in vitro anticancer activity. Bioorg. Med. Chem. 2010, 18, 8396–8402.
6
6. Vorbr u¨ ggen, H.; Krolikiewicz, K. Facile synthesis of N -substituted adenosines and adenines and
their 2-amino derivatives and 2-hydroxy derivatives. Justus. Liebigs. Ann. Chem. 1976, 4, 745–761.
7. Wan, Z.K.; Binnun, E.; Wilson, D.P.; Lee, J. A highly facile and efficient one-step synthesis of N6-
6
ꢁ
adenosine and N -2 -deoxyadenosine derivatives. Org. Lett. 2005, 7, 5877–5880.
8. Wan, Z.K.; Wacharasindhu, S.; Binnun, E.; Mansour, T. An efficient direct amination of cyclic amides
and cyclic ureas. Org. Lett. 2006, 8, 2425–2428.
9. Lescrinier, E.; Pannecouque, C.; Rozenski, J.; VanAerschot, A.; Kerremans, L.; Herdewijn, P. Synthesis
6
of N -alkylated adenosine derivatives. Nucleosides. Nucleot. 1996, 15, 1863–1868.
6
4
0. Adamska, E.; Barciszewski, J.; Markiewicz, W.T. Convenient and efficient syntheses of N - and N -
ꢁ
substituted adenines and cytosines and their 2 -deoxyribosides. Nucleosides. Nucleotides. Nucleic. Acids.
2012, 31, 861–871.
2
2
1. Jones, J.W.; Robins, R.K. Methylation studies of certain naturally occurring purine nucleosides. J.
Am. Chem.Soc. 1963, 85, 194–201.
2. a)Mikhailov, S. N.; Rozenski, J.; Efimtseva, E.V.; Busson, R.; Van Aerschot, A.; Herdewijn, P. Chem-
ical incorporation of 1-methyladenosine into oligonucleotides. Nucleic. Acids. Res. 2002, 30(5),
1
124–1131; b) Timofeev, E. N.; Mikhailov, S. N.; Zuev, A. N.; Efimtseva, E. V.; Herdewijn, P.; Somers,
ꢁ
R. L.; Lemaitre, M.M. Oligodeoxynucleotides containing 2 -deoxy-1-methyladenosine and Dimroth
rearrangement. Helv. Chim. Acta. 2007, 90(5), 928–937.
3. Tararov, V.I.; Kolyachkina, S.V.; Alexeev, C.S.; Mikhailov, S.N. N -Acetyl-2 ,3 ,5 -tri-O-
6
ꢁ
ꢁ
ꢁ
2
6
acetyladenosine; a convenient, ‘missed out’ substrate for regioselective N -alkylations. Synthesis. 2011,
2483–2489.
2
4. Fleysher, M.H.; Bloch, A.; Hakala, M.T.; Nichol, C.A. Synthesis and biological activity of some new
6
N -substituted purine nucleosides. J. Med. Chem. 1969, 12, 1056–1061.
6
2
5. Grimm, W.A.H.; Leonard, N.J. Synthesis of the “minor nucleotide” N -(γ ,γ -dimethylallyl)adenosine
ꢁ
6
5
-phosphate and relative rates of rearrangement of 1-to N -dimethylallyl compounds for base,
nucleoside, and nucleotide. Biochemistry. 1967, 6, 3625–3631.
2
6. Ottria, R.; Casati, S.; Manzocchi, A.; Baldoli, E.; Mariotti, M.; Maier, J.A.M.; Ciuffreda, P. Synthesis
and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives. Bioorg.
Med. Chem. 2010, 18, 4249–4254.